Donafenib for Previously Treated Metastatic Colorectal Cancer
Clinical trial NCT02870582 · COMPLETED
Trial details
- NCT number
- NCT02870582
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-28
- Primary completion
- 2020-04-30
- Enrollment
- 536
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.